← Leaderboards
Ah-Ng Tony Kong
University Of Illinois At Chicago
$19,827,201
Attributed
$19,827,201
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$19,827,201 · 9
By mechanism
R01$19,714,666 · 8
P30$112,535 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoGenesIn VitroCell LineMalignant NeoplasmsChemopreventive AgentMolecularClinical TrialsChemopreventionOxidative StressPreventBaseDesignAntioxidantsFutureApoptosisMouse ModelModificationTissuesCellsMalignant Neoplasm Of ProstateMediatingSignal PathwayTranscription Factor
Grant awards (65)
Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics$354,563
R01 · FY2020 · CA · contact PI
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease$670,130
R01 · FY2019 · AT · contact PI
Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics$343,925
R01 · FY2019 · CA · contact PI
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease$670,130
R01 · FY2018 · AT · contact PI
Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics$354,563
R01 · FY2018 · CA · contact PI
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease$666,025
R01 · FY2017 · AT · contact PI
Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics$354,563
R01 · FY2017 · CA · contact PI
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease$666,025
R01 · FY2016 · AT · contact PI
Curcuma Longa: epigenetic effects in prostate and colon cancer$463,811
R01 · FY2016 · AT · contact PI
Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics$354,563
R01 · FY2016 · CA · contact PI
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease$663,003
R01 · FY2015 · AT · contact PI
Curcuma Longa: epigenetic effects in prostate and colon cancer$449,898
R01 · FY2015 · AT · contact PI
Prostate cancer prevention by tocopherols$320,637
R01 · FY2015 · CA · contact PI
Epigenetic modifications by dietary PEITC in prostate cancer$266,709
R01 · FY2015 · CA · contact PI
Curcuma Longa: epigenetic effects in prostate and colon cancer$449,895
R01 · FY2014 · AT · contact PI
Prostate cancer prevention by tocopherols$311,017
R01 · FY2014 · CA · contact PI
Epigenetic modifications by dietary PEITC in prostate cancer$258,724
R01 · FY2014 · CA · contact PI
Curcuma Longa: epigenetic effects in prostate and colon cancer$449,897
R01 · FY2013 · AT · contact PI
Prostate cancer prevention by tocopherols$304,693
R01 · FY2013 · CA · contact PI
Epigenetic modifications by dietary PEITC in prostate cancer$251,705
R01 · FY2013 · CA · contact PI
Curcuma Longa: epigenetic effects in prostate and colon cancer$463,811
R01 · FY2012 · AT · contact PI
Prostate cancer prevention by tocopherols$325,335
R01 · FY2012 · CA · contact PI
Antioxidants and Antiinflammatory in Colorectal Cancer$270,299
R01 · FY2012 · CA · contact PI
Epigenetic modifications by dietary PEITC in prostate cancer$179,909
R01 · FY2012 · CA · contact PI
Prostate cancer prevention by tocopherols$324,121
R01 · FY2011 · CA · contact PI
Chemopreventive Functional Analysis of Nrf2$276,852
R01 · FY2011 · CA · contact PI
Epigenetic modifications by dietary PEITC in prostate cancer$271,249
R01 · FY2011 · CA · contact PI
Antioxidants and Antiinflammatory in Colorectal Cancer$270,299
R01 · FY2011 · CA · contact PI
Chemopreventive Functional Analysis of Nrf2$285,444
R01 · FY2010 · CA · contact PI
Antioxidants and Antiinflammatory in Colorectal Cancer$278,659
R01 · FY2010 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$260,445
R01 · FY2010 · CA · contact PI
Chemopreventive Functional Analysis of Nrf2$291,445
R01 · FY2009 · CA · contact PI
Antioxidants and Antiinflammatory in Colorectal Cancer$276,945
R01 · FY2009 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$260,445
R01 · FY2009 · CA · contact PI
Chemical Analysis Facility Core$112,535
P30 · FY2009 · ES · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$98,930
R01 · FY2009 · CA · contact PI
Chemopreventive Functional Analysis of Nrf2$293,335
R01 · FY2008 · CA · contact PI
Antioxidants and Antiinflammatory in Colorectal Cancer$276,945
R01 · FY2008 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$260,445
R01 · FY2008 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$58,386
R01 · FY2008 · CA · contact PI
Chemopreventive Functional Analysis of Nrf2$293,540
R01 · FY2007 · CA · contact PI
Chemopreventive Mechanisms of Isothiocyanates$270,760
R01 · FY2007 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$260,176
R01 · FY2007 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$56,804
R01 · FY2007 · CA · contact PI
Molecular Mechanisms of Phenolic Agent-induced Apoptosis$298,032
R01 · FY2006 · CA · contact PI
Chemopreventive Mechanisms of Isothiocyanates$278,847
R01 · FY2006 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$267,391
R01 · FY2006 · CA · contact PI
Chemopreventive Signaling Mechanisms in Prostate Cancer$47,035
R01 · FY2006 · CA · contact PI
Molecular Mechanisms of Phenolic Agent-induced Apoptosis$305,204
R01 · FY2005 · CA
Chemopreventive Mechanisms of Isothiocyanates$285,558
R01 · FY2005 · CA
Induction of Phase 2 Genes by Chemopreventive Agent BHA$283,187
R01 · FY2005 · CA
Molecular Mechanisms of Phenolic Agent-induced Apoptosis$305,204
R01 · FY2004 · CA
Chemopreventive Mechanisms of Isothiocyanates$285,558
R01 · FY2004 · CA
Induction of Phase 2 Genes by Chemopreventive Agent BHA$283,187
R01 · FY2004 · CA
Molecular Mechanisms of Phenolic Agent-induced Apoptosis$11,079
R01 · FY2004 · CA
Molecular Mechanisms of Phenolic Agent-induced Apoptosis$305,204
R01 · FY2003 · CA
Chemopreventive Mechanisms of Isothiocyanates$285,558
R01 · FY2003 · CA
Induction of Phase 2 Genes by Chemopreventive Agent BHA$283,187
R01 · FY2003 · CA
Molecular Mechanisms of Phenolic Agent-induced Apoptosis$11,079
R01 · FY2003 · CA
Molecular Mechanisms of Phenolic Agent-induced Apoptosis$305,204
R01 · FY2002 · CA
Induction of Phase 2 Genes by Chemopreventive Agent BHA$283,187
R01 · FY2002 · CA
REGULATION OF PHASE 2 GENES BY ISOTHIOCYANATES$258,166
R01 · FY2002 · CA
Induction of Phase 2 Genes by Chemopreventive Agent BHA$283,187
R01 · FY2001 · CA
REGULATION OF PHASE 2 GENES BY ISOTHIOCYANATES$256,818
R01 · FY2001 · CA
REGULATION OF PHASE 2 GENES BY ISOTHIOCYANATES$263,739
R01 · FY2000 · CA